Targeted Therapies Reshape Treatment Standards for FLT3-Mutated Acute Myeloid Leukemia
Targeted inhibitors and combination regimens are improving survival outcomes across clinical settings in FLT3-mutated acute myeloid leukemia.
Targeted inhibitors and combination regimens are improving survival outcomes across clinical settings in FLT3-mutated acute myeloid leukemia.
A 60-week observational study reveals that reflectance confocal microscopy detects persistent subclinical follicular inflammation in severe alopecia areata despite marked ...
A comprehensive review synthesizes evidence showing that sphenopalatine ganglion neurostimulation delivers rapid acute pain relief and sustained preventive benefits for ...
A study in Frontiers in Environmental Science shows that vertical stratification in constructed wetlands significantly impacts pollutant removal, with bottom ...
A narrative literature review reveals that advanced nanocarriers significantly enhance intracellular antibiotic accumulation and clearance of Brucella while highlighting critical ...
A pilot study in Ethiopia found that constructed wetlands effectively remove organic pollutants from septic tank effluent, though nutrient removal ...
A nationwide survey of Chinese urologists reveals that only 27.3 percent of eligible non-muscle-invasive bladder cancer patients receive Bacillus Calmette-Guérin ...
An anchored matching-adjusted indirect comparison indicates tralokinumab achieved higher rates of deep skin clearance and greater daily activity improvement than ...
An experimental mRNA therapy developed at the University of Cambridge stimulated heart muscle cell division and improved cardiac pumping function ...
A new study in Arthritis Research & Therapy shows that interleukin-2 treatment reduces lupus-associated lung bleeding in mice by correcting ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine